TCL Archive In Brief: Training Act Requires 75% Fr Institutional Grants, Rest For Individuals Fellowships September 27, 1974
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009